/Revvity%20Inc_%20stock%20chart%20and%20logo-by%20T_Schneider%20via%20Shutterstock.jpg)
Waltham, Massachusetts-based Revvity, Inc. (RVTY) is a leading provider of health science solutions, offering advanced technologies, expertise, and services that encompass complete workflows from discovery and development to diagnosis and cure. Valued at $12.9 billion by market cap, Revvity serves customers across healthcare, academia and governments, and employs over 11,000 people.
Companies worth $10 billion or more are generally described as "large-cap stocks," Revvity fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the diagnostics & research industry. Revvity revolutionizes what’s possible in healthcare and specializes in translational multi-omics technologies, prediction, screening, detection, diagnosis, and more.